Millennium Management’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.45M Sell
3,837,380
-296,768
-7% -$421K ﹤0.01% 2023
2025
Q1
$6.33M Buy
4,134,148
+2,175,101
+111% +$3.33M ﹤0.01% 1819
2024
Q4
$4.86M Sell
1,959,047
-1,046,551
-35% -$2.6M ﹤0.01% 2012
2024
Q3
$3.46M Sell
3,005,598
-331,252
-10% -$381K ﹤0.01% 2212
2024
Q2
$3.67M Buy
3,336,850
+63,358
+2% +$69.7K ﹤0.01% 2123
2024
Q1
$4.06M Sell
3,273,492
-205,869
-6% -$255K ﹤0.01% 2132
2023
Q4
$3.65M Buy
3,479,361
+1,511,381
+77% +$1.59M ﹤0.01% 2098
2023
Q3
$13.5M Buy
1,967,980
+1,140,896
+138% +$7.82M 0.01% 1204
2023
Q2
$8.58M Buy
827,084
+766,221
+1,259% +$7.95M ﹤0.01% 1572
2023
Q1
$492K Sell
60,863
-147,035
-71% -$1.19M ﹤0.01% 3434
2022
Q4
$3.27M Buy
207,898
+3,993
+2% +$62.9K ﹤0.01% 2374
2022
Q3
$3.21M Buy
203,905
+5,111
+3% +$80.4K ﹤0.01% 2534
2022
Q2
$2.78M Buy
198,794
+142,581
+254% +$1.99M ﹤0.01% 2621
2022
Q1
$969K Sell
56,213
-296,294
-84% -$5.11M ﹤0.01% 3605
2021
Q4
$5.13M Buy
352,507
+31,316
+10% +$455K ﹤0.01% 2215
2021
Q3
$5.78M Buy
321,191
+120,827
+60% +$2.17M ﹤0.01% 2042
2021
Q2
$3.52M Sell
200,364
-142,883
-42% -$2.51M ﹤0.01% 2535
2021
Q1
$8.65M Buy
343,247
+134,321
+64% +$3.38M 0.01% 1527
2020
Q4
$1.35M Sell
208,926
-72,872
-26% -$472K ﹤0.01% 2732
2020
Q3
$724 Sell
281,798
-103,137
-27% -$265 ﹤0.01% 2664
2020
Q2
$624K Buy
+384,935
New +$624K ﹤0.01% 2624
2020
Q1
Sell
-281,848
Closed -$533K 3096
2019
Q4
$533K Buy
281,848
+21,397
+8% +$40.5K ﹤0.01% 2720
2019
Q3
$281K Buy
260,451
+225,065
+636% +$243K ﹤0.01% 2987
2019
Q2
$77K Buy
35,386
+14,484
+69% +$31.5K ﹤0.01% 3372
2019
Q1
$125K Buy
+20,902
New +$125K ﹤0.01% 3279
2018
Q2
Sell
-110,827
Closed -$1.94M 3373
2018
Q1
$1.94M Buy
110,827
+99,029
+839% +$1.74M ﹤0.01% 2170
2017
Q4
$291K Buy
+11,798
New +$291K ﹤0.01% 3132
2017
Q3
Sell
-15,092
Closed -$409K 3198
2017
Q2
$409K Buy
15,092
+5,273
+54% +$143K ﹤0.01% 2664
2017
Q1
$293K Buy
+9,819
New +$293K ﹤0.01% 2824